삼성서울병원

Ko En

Radiation Oncology Yu, Jeong Il M.D

Expertise
Colorectal cancer, liver cancer, pancreatobiliary cancer, stomach cancer, sarcoma
Treament Schedule 10 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
TUE
31
AM
PM
Treament Schedule 11 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
AM
PM

Medical Education

2012~2017 Ph.D. in Medicine Sungkyunkwan University School of Medicine, Seoul, Korea
2008~2012 Master of Science Chungbuk National University, Chongju-si, Korea
1999~2005 M.D. in Medicine College of Medicine, CHA University, Korea
KGCP online education (2013. 4. 23)
SMC GCP offline education (2015.3.14)

Post-Graduate Training

Fellowship   2013~2015 Department of Radiation Oncology, Samsung Medical Center, Seoul
Residency   2006~2010 Department of Radiation Oncology, Samsung Medical Center, Seoul
Internship   2005~2006 Samsung Medical Center, Seoul, Korea

Professional Appointments

2019~Present Assistant Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
2015~2018 Clinical Instructor Department of Radiation Oncology, Samsung Medical Center, Seoul

Professional Memberships

2013~Present Member Korean Liver Cancer Association (KLCA)
2013~Present Member Korean Society of Medical Oncology (KSMO)
2013~Present Member Korean Cancer Association (KCA)
2010~Present Member Korean Society for Radiation Oncology (KOSRO)
2005~Present Member Korean Medical Association (KMA)

Selected Publications

  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • ANN ONCOL 2021 10.1016/j.annonc.2020.11.017 A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial Park1, SH; Lim, DH; Sohn, TS; Lee, J; Zang, DY; Kim, ST; Kang, JH; Oh, SY; Hwang, IG; Ji, JH; Shin, DB; Yu, JI; Kim, KM; An, JY; Choi, MG; Lee, JH; Kim, S; Hong, JY; Park, JO; Park, YS; Lim, HY; Bae, JM; Kang, WK
    View PubMed
  • CELLS 2021 10.3390/cells10030554 Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells Choi1, C; Lee, GH; Son, A; Yoo, GS; Yu, JI; Park, HC
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-82177-5 Clinical importance of the absolute count of neutrophils, lymphocytes, monocytes, and platelets in newly diagnosed hepatocellular carcinoma Yu1, JI; Park, HC; Yoo, GS; Choi, C; Choi, MS; Nam, H; Baek, SY; Park, M
    View PubMed
  • CANCERS 2021 10.3390/cancers13010059 Impact of Radiotherapy on Kidney Function among Patients Who Received Adjuvant Treatment for Gastric Cancer: Logistic and Linear Regression Analyses Park1, JS; Il Yu, J; Lim, D; Nam, H; Kim, YI; Lee, J; Kang, WK; Park, SH; Kim, ST; Hong, JY; Sohn, TS; Lee, JH; An, JY; Choi, MG; Bae, JM
    View PubMed